lobbying_activities: 823272
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 823272 | f29cb350-81d7-4573-b7fb-798070e4771e | Q3 | CAPITOL HILL CONSULTING GROUP | 72053 | ASTELLAS PHARMA US | 2009 | third_quarter | MMM | issues related to Medicare coverage of immunosuppressants; Medicaid payment for hospital-acquired conditions; the Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act (HR1458/S.565); America's Affordable Health Choices Act (HR3200); America's Healthy Future Act of 2009 | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2009-10-07T11:04:21-04:00 |